BURDEN OF ILLNESS OF PATIENS WITH CHRONIC LYMPHOCYTIC LEUKEMIA THAT ARE REFRACTORY TO FLUDARABINE AND ALEMTUZUMAB-CONTAINING REGIMENS IN SPAIN: AVERAGE COST ESTIMATION BY MONTECARLO SIMULATION - Parrondo Garcia, J; Loscertales Pueyo, J; Roldan Acevedo, C; Delgado Gonzalez, J (Haematologica, 2014)